CN101745182A - Device for improving action of head and device for preventing skin aging - Google Patents
Device for improving action of head and device for preventing skin aging Download PDFInfo
- Publication number
- CN101745182A CN101745182A CN200910221719A CN200910221719A CN101745182A CN 101745182 A CN101745182 A CN 101745182A CN 200910221719 A CN200910221719 A CN 200910221719A CN 200910221719 A CN200910221719 A CN 200910221719A CN 101745182 A CN101745182 A CN 101745182A
- Authority
- CN
- China
- Prior art keywords
- hydrogen
- brain activity
- ceramic plate
- generating
- plate unit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000009471 action Effects 0.000 title claims abstract description 8
- 230000009759 skin aging Effects 0.000 title claims description 45
- 239000001257 hydrogen Substances 0.000 claims abstract description 67
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 67
- 239000000919 ceramic Substances 0.000 claims abstract description 56
- -1 hydrogen ions Chemical class 0.000 claims abstract description 54
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 38
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 32
- 230000007177 brain activity Effects 0.000 claims description 54
- 230000002265 prevention Effects 0.000 claims description 35
- 210000004556 brain Anatomy 0.000 claims description 34
- 102000002274 Matrix Metalloproteinases Human genes 0.000 claims description 15
- 108010000684 Matrix Metalloproteinases Proteins 0.000 claims description 15
- 230000006698 induction Effects 0.000 claims description 13
- 238000007664 blowing Methods 0.000 claims description 9
- 230000006872 improvement Effects 0.000 claims description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 7
- 239000001301 oxygen Substances 0.000 claims description 7
- 229910052760 oxygen Inorganic materials 0.000 claims description 7
- 239000000428 dust Substances 0.000 claims description 6
- 230000033001 locomotion Effects 0.000 claims description 6
- 150000002500 ions Chemical class 0.000 claims description 5
- 239000007789 gas Substances 0.000 claims description 3
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 claims description 2
- 230000032683 aging Effects 0.000 abstract description 11
- 239000007921 spray Substances 0.000 abstract description 2
- 238000005507 spraying Methods 0.000 abstract 4
- 210000003491 skin Anatomy 0.000 description 38
- 210000003128 head Anatomy 0.000 description 25
- 230000000694 effects Effects 0.000 description 23
- 102000008186 Collagen Human genes 0.000 description 15
- 108010035532 Collagen Proteins 0.000 description 15
- 229920001436 collagen Polymers 0.000 description 15
- 230000002889 sympathetic effect Effects 0.000 description 10
- 206010040954 Skin wrinkling Diseases 0.000 description 9
- 210000005037 parasympathetic nerve Anatomy 0.000 description 9
- 230000037303 wrinkles Effects 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 8
- 230000007423 decrease Effects 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 8
- 230000006870 function Effects 0.000 description 7
- 230000008859 change Effects 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 108020004999 messenger RNA Proteins 0.000 description 6
- 210000005036 nerve Anatomy 0.000 description 6
- 210000002569 neuron Anatomy 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 5
- 230000008499 blood brain barrier function Effects 0.000 description 4
- 230000001149 cognitive effect Effects 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000002744 extracellular matrix Anatomy 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000003938 response to stress Effects 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 206010051246 Photodermatosis Diseases 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000001218 blood-brain barrier Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000036648 cognitive speed Effects 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000004498 neuroglial cell Anatomy 0.000 description 3
- 230000008845 photoaging Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 210000004761 scalp Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 210000000467 autonomic pathway Anatomy 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000002449 bone cell Anatomy 0.000 description 2
- 230000003925 brain function Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000036570 collagen biosynthesis Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000004424 eye movement Effects 0.000 description 2
- 210000001061 forehead Anatomy 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000001734 parasympathetic effect Effects 0.000 description 2
- 210000001002 parasympathetic nervous system Anatomy 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000011241 protective layer Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 210000002820 sympathetic nervous system Anatomy 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 206010064996 Ulcerative keratitis Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 102000036861 Zinc-dependent endopeptidases Human genes 0.000 description 1
- 108091006982 Zinc-dependent endopeptidases Proteins 0.000 description 1
- IHBCFWWEZXPPLG-UHFFFAOYSA-N [Ca].[Zn] Chemical compound [Ca].[Zn] IHBCFWWEZXPPLG-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 230000004397 blinking Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 201000007717 corneal ulcer Diseases 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 229940066758 endopeptidases Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000010365 information processing Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 210000003622 mature neutrocyte Anatomy 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 238000006552 photochemical reaction Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 230000009323 psychological health Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008700 sympathetic activation Effects 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000001186 vagus nerve Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Electrotherapy Devices (AREA)
Abstract
The present invention discloses a device for improving the action of the head, which sprays the air current produced an air current producer to the head and comprises a box, an air inlet arranged on one side of the box; an air current producer comprising a ceramic plate unit for producing hydrogen ions and an electron generation unit spaced from the ceramic plate unit for generating electrons and superoxide radicals; and a spraying opening for spraying the superoxide radicals produced by the air current producer and hydrogen atoms to the head. The present invention further discloses a device for preventing skin from aging by using a hydrogen producer, comprising: a box; an air inlet arranged on one side of the box; a hydrogen producer for producing hydrogen atoms; and a spraying opening for spraying the hydrogen atoms produced by the hydrogen producer to the skin, wherein the hydrogen producer comprises a ceramic plate unit for producing hydrogen ions and an electron generation unit spaced from the ceramic plate unit for generating electrons.
Description
Technical Field
The present invention relates to a brain activity improving machine, and more particularly, to a brain activity improving machine that injects an air flow generated by an air flow generating device to a head.
The present invention also relates to an apparatus for preventing skin aging, and more particularly, to an apparatus for preventing skin aging capable of preventing skin aging using a hydrogen generating device.
Background
The quality of the indoor air also has a psychological and psychological impact on the occupants of the room. For example, the generation of pollutants from multiple indoor sources can cause asthma, allergic diseases, which can lead to a reduction in concentration and, as a result, hamper performance. Indeed, reports (Fisk, 2000; Meldelet et al, 2002a) have shown that the quality of indoor air can affect the efficiency of workers working in an empty space. Also, Seppa nen et al, (2006) quantitatively analyzes and reports the indoor air quality improvement from indoor space ventilation versus work performance capability.
As indoor environments need to ensure not only physical health but also mental and psychological health of indoor occupants, the function and effect of indoor air are gradually increasing, and with this demand, the necessity of technical development for the purpose of creating comfortable indoor environments is also gradually emerging.
Wherein especially learning space and business space require an improved mental activity to be maximally efficient. In order to create such a space, it is attempted to improve human brain activities by using an airflow generating device, and the following brain waves and electrocardiogram characteristics are used as an index for evaluating the objectivity of such brain activities.
Generally, the brain wave refers to a scalp brain wave obtained from a scalp electrode (scalp EEG). Electroencephalograms (EEG) are a simple examination method for the objective, non-invasive, continuous assessment of brain function.
In short, it is known from the brain waves whether the brain function, in particular the activity of the brain, is weakened or, conversely, enhances this. An objective index showing the activity level of the brain can be obtained. Therefore, the electroencephalogram (EEG) test is recognized in value because it is possible to grasp the change in brain activity that changes from time to time in space and time.
The electrical activity of the brain, which is reflected in brain waves, is determined by nerve cells (neurones), glial cells (glial cells), blood-brain barrier (blood-brain barrier), and is mainly produced by nerve cells. The glue cells occupying half of the brain weight regulate the flow of ions and molecules through the nerve bonds, which are the parts connected with nerve cells, and play a role in maintaining, supporting and repairing the structures among the nerve cells. The blood brain barrier functions to select only necessary substances from various substances in the cerebral blood vessels and allow them to pass through. The change of brain waves generated by the glial cells and the blood brain barrier occurs gradually at a point, whereas the change of brain waves generated by the activity of nerve cells occurs largely, rapidly, and variously.
Generally, brain waves are artificially differentiated according to the range of vibration frequencies and are called delta waves (delta waves) (0.2-3.99Hz), theta waves (theta waves) (4-7.99Hz), alpha waves (alpha waves) (8-12.99Hz), beta waves (beta waves) (13-29.99Hz), and gamma waves (gamma waves) (30-50 Hz).
The delta wave appears predominantly in normal people at deep sleep or in neonates. If a person who is awake presents a very large number of delta waves than the average range, a malignancy or a disease associated with anesthesia, lethargy, etc. on the cerebral cortex may be suspected. If the delta wave ratio is significant in a healthy normal person, it is mostly due to blinking of the eyes or vigorous movement of the body at the time of brain wave detection. The frequency range of noise generated according to such an eye movement or a body movement almost coincides with the frequency range of the δ wave, and therefore it is as if the δ wave is increased. Therefore, in general, when a brain wave detection experiment is performed for a long time, since eye movement or body movement inevitably occurs, the increase or decrease in the power of the δ wave is not generally considered as an analysis element.
The θ wave is a wave that mainly occurs during the mood to calm or sleep, and is more distributed in children than adults. It has been reported that the θ wave is associated with various states including states of memory, peculiar function, originality, concentration, and unresolved solution.
The α wave mainly appears in a relaxed state such as a relaxed state, and the more stable and relaxed state, the larger the amplitude. Generally occurring continuously in a regular undulating shape, with the characteristic of recording being greatest at the top and back of the head and smallest at the forehead. When a particularly stable alpha wave appears, the alpha wave can be suppressed if the eyes are closed and calmed down. This phenomenon is called "alpha wave stopping". The alpha wave is closely related to the development of the brain, and is detected as 4-6Hz in the early childhood, but then the frequency increases with age, and reaches the value of an adult when the age is about twenty years.
The beta wave appears mainly in the forehead, and appears when all conscious activities are performed, such as waking up and speaking. In particular, when the system is in an unstable state or under stress, it is preferable to perform complicated calculation processing.
It has been reported that gamma waves have a shape which vibrates faster than beta waves, and are deeply involved in high-level cognitive information processing such as the state of being scorched or reasoning and judgment.
The δ wave, θ wave, α wave, β wave, and γ wave are frequency ranges of the brain waves that are artificially classified for convenience. Some scholars also perform analyses by further subdividing into Low-alpha waves, Middle-alpha waves, High-alpha waves, and the like. In general, when a researcher analyzes brain wave characteristics in a specific state, the researcher first observes a power spectrum distribution that reflects the power distribution of each frequency component of 0 to 50Hz as a whole, searches for a frequency component that changes meaningfully, and gives it a meaning.
The electrocardiogram is a signal reflecting the electrical activity of the heart functioning as a blood circulation pump, and shows a shape corresponding to various continuous peaks of the P-Q-R-S-T wave. In general, the highest peak in both directions corresponds to an R peak, which repeatedly appears with each heartbeat.
Generally, shape inspection of each electrocardiogram waveform composed of PQRST is useful for diagnosing various heart diseases caused by organic lesions of the heart, whereas time interval information between consecutive R peaks is useful for evaluating the function of autonomic nerves. Such an interval between R peaks, i.e., a change in the heartbeat interval, is called a heart rate variability, which is also called R-interval variability. In general, the heart beat interval can be indirectly extracted from a pulse, heart sound, or the like under a specific error (wave error) range, and is specifically and standardly named as R-interval variability indicating an electrocardiogram, because it is preferable to use an R peak value that is much clearer than other signal rules in order to obtain accurate heart beat interval information.
The occurrence of the R peak in the electrocardiogram appears to be very regular, but actually investigating the intervals with quantitative values varies slightly with each heartbeat. That is, when changes in RR intervals in an electrocardiographic signal measured for five minutes are represented in a graph, the electrocardiographic signal may have a random oscillation shape that is slightly high or low within a certain range. The international heart society recommends measurements of five minutes for the sake of correct and highly reproducible quantitative variables in clinical practice. The subtle patterns of variation in this RR interval are largely dependent on the activity of the autonomic nervous system (sympathetic and parasympathetic nervous systems) to which the stress response is most sensitive. Therefore, the RR interval variation pattern is effectively applied to stress response tests in addition to basic autonomic nerve abnormality tests.
In general, the activity level of the sympathetic nervous system increases mainly in an aggressive and defensive stress response state, while the activity level of the parasympathetic nervous system increases in a soothing and relaxing state. For example, in an initial stress response state, the activity of the sympathetic nerves first increases, and this high activity of the sympathetic nerves induces an increase in the number of heartbeats, an increase in blood pressure and blood sugar, an increase in blood flow to voluntary muscles, secretion of sweat, a decrease in blood flow to internal organs, and the like. On the contrary, when the body is relaxed with ease, the activity of parasympathetic nerves increases, and the decrease in the heart rate and blood pressure, the increase in salivary secretion, the enhancement of intestinal movement, sleep, and the like are induced.
When the sympathetic and parasympathetic nerves are stimulated, the reaction time of the sympathetic nerves lags behind the parasympathetic nerves by about five seconds. Thus, sympathetic activation induces a slower pattern of RR interval changes and a relatively faster pattern of parasympathetic (vagus nerve) changes. This makes it possible to independently measure the activity levels of sympathetic and parasympathetic nerves from the RR interval change pattern by quantitative variables such as the power of a component that vibrates slowly (LF: LowFrequency) and the power of a component that vibrates rapidly (HF: High Frequency).
When one of the sympathetic and parasympathetic nerves is excessively activated, the other one tries to prevent it to perform a mutual regulation action. In order to grasp whether the function of such mutual regulation is being performed normally, it is necessary to investigate the ratio of the sympathetic activity degree (autonomic balance index) to the parasympathetic nerve. If the state in which the activity is biased toward parasympathetic or sympathetic is maintained for too long, the nerve, which has a high activity, is at risk of being depleted of energy and eventually losing its function.
In addition, human skin is constantly changing, and the most typical examples thereof are reduction in skin function and visual aesthetic sense due to aging. Aging of the skin is mainly classified into intrinsic aging due to genetic factors and extrinsic aging due to external environmental factors such as sunlight. Such external aging includes wrinkles formed in the skin, and typical factors of wrinkles include reduction in active oxygen, ultraviolet rays, and collagen biosynthesis.
It is impossible to artificially regulate intrinsic aging of the skin, but it is possible to regulate extrinsic aging more easily than intrinsic factors by eliminating active oxygen, increasing fibroblasts, promoting collagen biosynthesis, and the like.
The human skin varies greatly over time in terms of quantity and quality. In addition to this natural aging, it is also stimulated from various external environments. That is, a series of changes are caused by changes in the molecular biology and external physical and chemical factors. In particular, damage caused by ultraviolet rays (ultraviolet rays) in sunlight is called photo aging (photo aging), and studies on this are actively conducted. Generally, the ultraviolet rays can be classified into three types, i.e., ultraviolet ray A (320-400nm), ultraviolet ray B (280-320nm), and ultraviolet ray C (190-280nm), according to their wavelengths. Among sunlight reaching the earth surface, ultraviolet rays C are absorbed, scattered, and filtered by the ozone layer in the upper layer of the atmosphere, and therefore do not particularly affect the natural photochemical reaction. The ultraviolet ray a is first emitted from the sun, but is also emitted from a human illuminator or the like, and penetrates the epidermis and deep dermis of the skin. Therefore, at present, the ultraviolet ray a is considered to be the most influential factor to the skin and is receiving attention. However, the irradiation of the ultraviolet ray B is more dangerous than the ultraviolet ray a. That is, it is considered that the wavelength of the ultraviolet ray B is shorter than that of the ultraviolet ray a, and therefore, the ultraviolet ray B cannot penetrate into the deep part of the skin, but has a very strong energy than that of the ultraviolet ray a, and therefore, the ultraviolet ray B causes a marked erythema on the skin surface and is considered as a wavelength for promoting photoaging of the skin. Damage of the skin by ultraviolet rays includes a case where active oxygen species formed by ultraviolet rays send signals to a cell signaling system, and as a result, Matrix Metalloproteinases (MMPs) are synthesized, and the MMPs decompose collagen and gel (gelatin), which are extracellular matrix (ECM) components of the skin, and the like, thereby breaking down the collagen and gel, resulting in wrinkles of the skin.
Collagen is a major basic protein produced in fibroblasts of the skin, is present in extracellular matrix, is an important protein accounting for about 30% of the total weight of biological proteins, and has a strong triple helix structure. The main functions include mechanical firmness of the skin, resistance and cohesion of the bonded tissues, support of cell adhesion, induction of cell division and differentiation, and the like. Collagen is also destroyed by exposure to ultraviolet light, an external cause of which is considered to be skin aging, and the change caused by ultraviolet light is proportional to the time of exposure to ultraviolet light. The ultraviolet rays accumulate elastic fibrous substances in the dermis layer of the skin and denature collagen fibers, resulting in wrinkles in the skin and reduced elasticity.
On the other hand, MMPs are calcium-and zinc-dependent endopeptidases (endopeptidases) secreted from cells such as neutrophils (Polymorphonuclear neutrophiles), macrophages (macrophages), gingival fibroblasts (fibroplasts), and Bone cells (Bone cells), and act at neutral PH, and various extracellular matrices are used as matrices. Such a protease is considered to be involved in various diseases and pathological processes such as embryo formation, tissue formation, metastasis of cancer, periodontal disease, articular rheumatism, inflammation, diabetes, corneal ulcer, osteoporosis, gastric ulcer, trauma, skin aging and wrinkle, burn and wound treatment.
Further, the importance of the function of collagen in the skin has been increasingly recognized with the progress of studies on the prevention and treatment of wrinkles, and these studies have shown that the metabolism of collagen is activated by the synthesis of collagen in the skin, and that the collagen has effects of increasing the components of the dermal tissue, improving wrinkles, increasing elasticity, and strengthening the skin.
The aging process of the skin can be briefly explained as follows. That is, exposure to ultraviolet rays reduces the production of intradermal protein (collagen), and increases MMP as a proteolytic enzyme (collagenase). Wrinkles in the skin are directly associated with a decrease in collagen in the dermis, which is caused by a decrease in collagen and an increase in proteolytic enzymes accompanying skin aging. Therefore, a solution is needed to reduce the concentration of MMPs that hinder collagen synthesis in organisms.
Disclosure of Invention
One aspect of the present invention discloses a brain activity improving machine which sprays a comfortable air flow to a head in order to improve learning efficiency and work efficiency, thereby improving brain activity.
In addition, a skin aging prevention machine capable of preventing aging of skin (mainly face) is also disclosed.
In order to achieve the above object, a brain activity improving apparatus according to the present invention is characterized by including an airflow generating device that changes a brain wave and an electrocardiogram.
The airflow generating device includes: a ceramic plate unit for generating hydrogen ions; and an electron generation unit disposed spaced apart from the ceramic plate unit for generating electrons and negative ions.
The ceramic plate unit includes a discharge electrode and an induction electrode, and a positive high voltage is applied between the discharge electrode and the induction electrode to generate hydrogen ions.
The electron generating unit comprises a needle electrode, and electrons are discharged into the air when negative high voltage is applied to the needle electrode; the electrons combine with oxygen molecules in the air to generate superoxide ions (O)2 -) And combines with the hydrogen ion to generate a hydrogen atom (H).
Further, a brain activity improving machine according to an aspect of the present invention includes: a box body; an air suction inlet formed at one side of the case; the gas flow generating device comprises a ceramic plate unit for generating hydrogen ions and an electron generating unit which is arranged at a distance from the ceramic plate unit and is used for generating electrons and superoxide ions; and an ejection port for ejecting the superoxide ions and hydrogen atoms generated by the airflow generating device to the head.
The brain activity improving machine further comprises an air supply device.
The brain activity improving machine further includes a recognition sensor that recognizes the head.
The brain activity improving machine further comprises a control unit for controlling the action.
The brain activity improving machine further includes a dust filter at the air intake port.
The recognition sensor is used for recognizing the front of the head.
The recognition sensor is used for recognizing the right side surface of the head.
The brain movement improving machine further includes a rotating motor that rotates the direction of the ejection port in accordance with the portion identified by the identification sensor.
In addition, a skin aging prevention machine according to an idea of the present invention is characterized by comprising: a box body; an air suction inlet formed at one side of the case; a hydrogen generating means for generating hydrogen atoms; an ejection port that ejects hydrogen atoms generated by the hydrogen generation device to the skin; the hydrogen generating apparatus includes a ceramic plate unit for generating hydrogen ions and an electron generating unit spaced apart from the ceramic plate unit for generating electrons.
The ceramic plate unit includes a discharge electrode and an induction electrode, and a positive high voltage is applied between the discharge electrode and the induction electrode to generate hydrogen ions.
The electron generating unit is a needle electrode, and when a negative high voltage is applied to the needle electrode, electrons are emitted into the air, and the electrons are combined with the hydrogen ions to generate hydrogen atoms (H).
The hydrogen atom reduces the concentration of mmp (matrix metalloproteinase) in the skin.
The skin aging prevention apparatus further includes an air blowing device for sending the hydrogen ions generated by the ceramic plate unit to the electrons emitted by the needle electrodes.
The skin aging prevention apparatus further includes a control unit for controlling the hydrogen generation device and the air supply device.
The skin aging prevention machine further includes a hair band for being brought onto the face.
The brain activity improving machine according to one embodiment of the present invention described above ejects the air flow generated by the air flow generating device to the head, thereby improving the brain activity, learning efficiency, and work efficiency.
In addition, according to the skin aging prevention apparatus of the embodiment of the present invention described above, the hydrogen atoms generated by the hydrogen generating device are ejected onto the skin, and the concentration of mmp (matrix metalloproteinase) in the skin is reduced based on the ejected hydrogen atoms, thereby preventing the skin aging.
Drawings
Fig. 1 is a conceptual diagram illustrating a brain activity improving machine including an air flow generating device;
FIG. 2A is a schematic view of an airflow generating device;
fig. 2B is a diagram showing in detail the airflow generation principle of the airflow generation device;
FIG. 3A is one embodiment of an airflow generating device according to the invention;
FIG. 3B is another embodiment of an airflow generating device according to the invention;
FIG. 3C is yet another embodiment of an airflow generating device according to the invention;
FIG. 3D is yet another embodiment of an airflow generating device according to the invention;
FIG. 3E is yet another embodiment of an airflow generating device according to the invention;
FIG. 3F is yet another embodiment of an airflow generating device according to the invention;
fig. 4 is a state diagram of the use of the brain activity improving machine according to the present invention;
fig. 5 is a perspective view showing a hydrogen-generating apparatus according to still another embodiment of the present invention;
fig. 6 is a conceptual diagram of a skin aging prevention machine according to still another embodiment of the present invention;
fig. 7A is a perspective view of a skin aging prevention machine according to still another embodiment of the present invention;
fig. 7B is a perspective view of a skin aging prevention machine according to still another embodiment of the present invention;
fig. 8A is experimental data showing relative concentrations of mmps (matrix metalloproteinases) with and without the skin aging prevention machine according to still another embodiment of the present invention;
FIG. 8B is experimental data showing the relative concentrations of mRNA when the skin aging prevention machine according to still another embodiment of the present invention is used and not used;
wherein, 20, 30, 40, 50, 60 and 70 are box bodies; 21. 31, 41, 51, 61 and 71 are air suction ports; 26. 36, 46, 56, 66 and 67 are ejection ports; 100 is an air flow generating device; 110 is a body; 111 is a ceramic plate unit; 112 is a needle electrode; 114 is a discharge electrode; 115 is a sensing electrode; 200 is an air supply device; 210 is a blower fan; 220 is a motor; 300 is an identification sensor; 400 is a control unit; 410 is a display unit; 420 is an operation unit; 430 is a power supply unit; 500 is a rotating electrical machine; 800 is a head; 10a and 20a are box bodies; 11a and 21a are air suction ports; 15a and 25a are ejection ports; 100a is a hydrogen generating device; 110a is a body; 111a is a ceramic plate unit; 112a is a needle electrode; 114a is a discharge electrode; 115a is a sensing electrode; 200a is an air supply device; 300a is a control unit; 310a is a display unit; 320a is an operation unit; 330a is a power supply unit; 800a is the head.
Detailed Description
Hereinafter, one embodiment of the present invention will be described in detail based on the drawings.
Fig. 1 is a conceptual diagram illustrating a brain activity improving machine including an air flow generating device. Fig. 2A is a schematic view of an airflow generating apparatus, fig. 2B is a view showing in detail an airflow generating principle of the airflow generating apparatus, fig. 3A is one embodiment of the airflow generating apparatus according to the present invention, fig. 3B is another embodiment of the airflow generating apparatus according to the present invention, fig. 3C is yet another embodiment of the airflow generating apparatus according to the present invention, fig. 3D is yet another embodiment of the airflow generating apparatus according to the present invention, fig. 3E is yet another embodiment of the airflow generating apparatus according to the present invention, fig. 3F is yet another embodiment of the airflow generating apparatus according to the present invention, and fig. 4 is a use state view of the brain activity improving machine according to the present invention.
Referring to fig. 1 to 3A, a brain activity improving machine according to an embodiment of the present invention includes a case 20; an air suction port 21 formed at a lower portion of the case 20 to constitute an air suction passage; a dust filter 23 disposed inside the air suction port for filtering dust; an airflow generating device 100 for improving the activity of the head; an air supply device 200 provided at one side of the airflow generating device 100; a control unit 400 for controlling the action of the mental activity improvement machine; an ejection port 26 for ejecting the air flow generated by the air flow generating device 100 to the head; a recognition sensor 300 provided inside the discharge port 26 for recognizing the head; the rotating electric machine 500 is electrically connected to the recognition sensor 300, and rotates the upper case 28 according to the recognized part of the recognition sensor 300.
The case 20 is composed of an upper case 28 and a lower case 29. An ejection port 26 for ejecting the air flow is formed in the upper case 28, and a recognition sensor 300 is mounted inside the ejection port. An air suction port 21 is formed in the lower portion of the lower case 29, a dust filter 23, an air blowing device 200, and an air flow generating device 100 are provided in the lower portion, and a control unit 400 is provided on the outer surface of the lower case 29. The upper case 28 is coupled to the lower case 29 so as to be rotatable, and a rotating motor 500 is provided at the coupling position, so that the direction of the ejection port 26 can be changed by rotating the upper case 28 in accordance with the recognition portion (the front surface or the right side surface of the head) of the recognition sensor 300.
The control unit 400 includes a display unit 410 for displaying an action state of the mental activity improvement machine; an operation unit 420 for adjusting the operation and blowing speed of the airflow generating device 100 and the blowing device 200; a power supply unit 430 for supplying power to the brain activity improving apparatus.
As shown in fig. 1, 2A and 2B, the air flow generating apparatus 100 includes a ceramic plate unit 111 disposed on an upper surface of a body 110; and a needle-shaped electrode 112 disposed at a predetermined distance from the ceramic plate unit 111.
The upper surface of the body 110 is provided with a space recessed for disposing the ceramic plate unit 111, and the ceramic plate unit 111 is embedded in the space. The ceramic plate unit 111 is a unit for generating hydrogen ions, and a discharge electrode 114 is provided above the inside of the ceramic plate unit 111, and an induction electrode 115 is provided at the center of the inside. The parts other than the discharge electrode 114 and the inductive electrode 115 are formed of ceramics to form a protective layer.
A positive high voltage is applied between the discharge electrode 114 and the induction electrode 115. When a positive high voltage is applied between the discharge electrode 114 and the inductive electrode 115, moisture (H) in the air is generated in the ceramic plate unit 111 by the plasma discharge2O) is electrolyzed to generate hydrogen ions (H)+)。
On the other hand, a negative high voltage is applied between the needle electrode 112 and the ground electrode 117. When a negative high voltage is applied to the needle electrode 112 in this way, positive ions are collected around the needle electrode 112 by plasma discharge, and a large number of electrons are emitted from the needle electrode 112 into the air. Since a large number of electrons emitted into the air are very unstable, oxygen molecules (O) are generated2) Capture to form superoxide ion (O)2 -). Therefore, when a negative high voltage is applied to the needle electrode 112, electrons (e) and superoxide ions (O) are generated2 -)。
Further, if electrons are emitted from the needle electrodes 112, the electrons are combined with hydrogen ions generated by the ceramic plate unit 111 and passing through the periphery of the needle electrodes 112, and hydrogen atoms (or active hydrogen) are generated. At this time, the blower 200 provided on one side of the airflow generating device 100 forcibly sends the hydrogen ions generated from the ceramic plate unit 111 to the needle electrodes 112 so as to be well combined with the electrons generated from the needle electrodes 112. The blower 200 includes a blower fan 220 and a motor 210 for rotating the blower fan.
The needle-shaped electrodes 112 are disposed at a predetermined distance from the ceramic plate unit 111. The number of hydrogen ions generated from the ceramic plate unit 111 converted into hydrogen atoms varies with the separation distance between the needle electrodes 112 and the ceramic plate unit 111, and thus it is preferable to adjust the separation distance between the two according to the size of the ceramic plate unit 111, the height of the needle electrodes 112, and the like.
As described above, the hydrogen ions generated by the ceramic plate unit 111 are combined with the electrons emitted from the needle electrodes 112 to generate hydrogen atoms, and thus, the substances finally discharged from the gas flow generator 100 are hydrogen atoms (H) and superoxide ions (O)2 -)。
The ejection port 26 is provided so that the hydrogen atoms and superoxide ions can be ejected to the head 800. Although this ejection port 26 is shown as a circular surface formed with a plurality of holes in fig. 3A, it may be any shape that facilitates discharge of the air flow to the head. The ejection port 26 may be replaced with another shape as necessary.
Next, the operation process of the brain activity improvement device and the brain activity improvement method will be described by a preferred first embodiment according to the present invention.
When the user operates the operation unit 420 provided in the control unit 400 to operate the brain activity improving apparatus, the air sucked from the air suction port 21 is sent to the airflow generating device 100. Hydrogen ions are generated using air by applying a positive high voltage between the discharge electrode 114 and the induction electrode 115 of the ceramic plate unit 111, and electrons and superoxide ions are generated by applying a negative high voltage to the needle electrodes 112. Then, the hydrogen ions flow through the needle electrode 112 or the periphery of the needle electrode 112 by the air blown by the air blowing device 200. The hydrogen ions near the needle electrode 112 are combined with electrons around the needle electrode 112 to become hydrogen atoms, and are discharged from the ejection port 26 to the outside together with the superoxide ions generated by the needle electrode 112.
The discharged hydrogen atoms and superoxide ions are sprayed to the head 800 of the human body. At this time, the recognition sensor 300 recognizes the front or right side surface of the head 800, and rotates the rotary motor 500 so that the direction of the discharge port 26 is directed toward the front or right side surface of the head 800. The recognition sensor 300 is made to recognize the front or right side of the head 800 because the brain activity improvement effect is the highest when the air flow is toward the front or right side of the head 800. This point will be described in detail later.
Also, the air flow generated by the air flow generating means 100 is preferably ejected at a speed of 0.3m/s to 0.5m/s at a distance of 50cm to 150cm from the head. Similarly, the reason is that the effect of improving the brain activity is remarkable at this time. This will be described later.
Next, experiments using the brain activity improving machine and experimental results will be described.
Experiment brain waves when exposed to airflow during learning were measured for 8 high school students (4 men and 4 women), 8 middle school students (4 men and 4 women), and 6 elementary school students (3 men and 3 women), and the measurement results were analyzed and compared. The brain wave characteristics when the brain wave was learned in a state of not being exposed to the airflow and the brain wave characteristics when exposed to the airflow were compared and analyzed, taking exposure to the airflow as a stimulus. The brain wave characteristics used for analysis are relative power, SEF-90, concentration index, and tranquilization index.
The relative power indicates the relative ratio of the vibration components occurring in this range with respect to the full range. Therefore, analysis variables such as relative θ, relative α, relative β, and relative γ powers are used for the analysis of the relative powers. Since the units of the numerator and denominator are approximately fraction, the relative power has no units, representing a value between 0 and 1. The SEF-90 is a specific frequency value when the area from the left side (Low-edge) of the frequency to the specific frequency in the power spectrum occupies 90% of the area of the entire frequency range, and is an analysis variable that is significant for quantifying the brain arousal. A concentration index calculated by the ratio of SMR (late β power) to M Beta (intermediate β power) with respect to θ power, and a stability index calculated by the ratio of α power to High-Beta (High β power) are also calculated using the measured brain waves.
Brain waves, electrocardiograms, and learning activities are measured for students, characteristics of each index are grasped, and a correlation between the indexes is analyzed to comprehensively analyze the characteristics.
The correlation between the indices of the 22 persons who participated in the experiment was analyzed from the results of the 17-fold measurement of each person for 254 measurement data in total, and the results are shown in table 1.1 below. The correlation coefficients for the relative β, relative γ, concentration index, and SEF-90 with respect to the relative θ are strongly negative correlations such as-0.88, -0.78, -0.81, and-0.84, respectively, and the correlation coefficient for the stability index is positively correlated with 0.58. It was confirmed that the θ wave is a brain wave related to drowsiness, and shows a negative correlation with an index which can be described in connection with strong brain activities and learning, such as a β wave, a γ wave, a concentration index, and an SEF-90 index.
The α wave and the stability index show a positive correlation (r is 0.59), the β wave and the γ wave (r is 0.66), the concentration index (r is 0.81), and SEF90(r is 0.75), and the stability index (r is-0.70). The stability index showed a strong negative correlation with SEF90(r is-0.81), and this indicates that the degree of stability decreased as the brain wave became more alert.
< TABLE 1.1> analysis of correlation between electroencephalogram indexes
| Relative theta | Relative alpha | Relative beta | Relative gamma | Central index | Stability index | SEF90 | |
| Relative theta | 1.00 | ||||||
| Relative alpha | -0.04 | 1.00 | |||||
| Relative beta | -0.88 | -0.18 | 1.00 | ||||
| Relative gamma | -0.78 | -0.46 | 0.66 | 1.00 | |||
| Central index | -0.81 | 0.00 | 0.81 | 0.59 | 1.00 |
| Relative theta | Relative alpha | Relative beta | Relative gamma | Central index | Stability index | SEF90 | |
| Stability index | 0.58 | 0.59 | -0.70 | -0.70 | -0.41 | 1.00 | |
| SEF90 | -0.84 | -0.34 | 0.75 | 0.91 | 0.58 | -0.81 | 1.00 |
Next, table 1.2 below shows the correlation analysis results between the indicators obtained from the data of 110 individuals in total, for the case of not being exposed to the airflow and the case of being exposed to the airflow (0.5m/s), in which 5 electrocardiographic measurements were performed for each individual according to the direction of exposure to the airflow. The average RR interval is positively correlated with the parasympathetic nerve cells HF (r is 0.51), and the average heartbeat interval (SDNN) is positively correlated with the sympathetic nerve index LF, the parasympathetic nerve index HF, and RSA. Further, it was confirmed that HF of the parasympathetic nerve index and RSA showed a positive correlation (r ═ 0.72).
< TABLE 1.2> analysis of correlation between electrocardiographic indexes
| M-RRI | SDNN | LF | HF | LF/NF | RSA | |
| M-RRI | 1.00 | |||||
| SDNN | 0.38 | 1.00 | ||||
| LF | -0.05 | 0.76 | 1.00 | |||
| HF | 0.51 | 0.59 | 0.04 | 1.00 | ||
| LF/NF | -0.24 | 0.29 | 0.76 | -0.45 | 1.00 | |
| RSA | 0.25 | 0.77 | 0.54 | 0.72 | 0.06 | 1.00 |
Next, from the evaluation results of the correlation between the respective indices in the learning ability evaluation results of table 1.3 below, it can be seen that only the concentration and the workload degree show a strong positive correlation, and the correlation coefficient thereof is 0.59. This is considered to be because the brain becomes active when the concentration increases, and the brain becomes more awake.
< Table 1.3> evaluation of correlation between indices in learning ability evaluation results
| Rate of answer correctness | Rate of answer errors | Cognitive strength | Cognitive speed | Concentrated force | Degree of workload | Degree of left brain Activity | Degree of right brain Activity | |
| Rate of answer correctness | 1.00 | |||||||
| Rate of answer errors | -0.54 | 1.00 |
| Rate of answer correctness | Rate of answer errors | Cognitive strength | Cognitive speed | Concentrated force | Degree of workload | Degree of left brain Activity | Degree of right brain Activity | |
| Cognitive strength | -0.04 | 0.14 | 1.00 | |||||
| Cognitive speed | -0.01 | 0.06 | 0.10 | 1.00 | ||||
| Concentrated force | -0.10 | 0.00 | 0.03 | -0.03 | 1.00 | |||
| Degree of workload | -0.25 | 0.22 | 0.02 | 0.00 | 0.59 | 1.00 | ||
| Degree of left brain Activity | -0.05 | 0.00 | -0.24 | 0.06 | 0.09 | 0.27 | 1.00 | |
| Degree of right brain Activity | 0.05 | 0.00 | 0.24 | -0.06 | -0.09 | -0.27 | -1.00 | 1.00 |
Next, the direction of airflow and the strength of airflow, which positively affect the learning activity, were investigated using four directional variables (front, rear, left, right) and wind speed variables (0.1, 0.3, 0.5, 1.0m/s), and as a result, "θ waves" related to drowsiness decreased when exposed to airflow from the front and right of the learner, whereas "β waves/γ waves" and "concentration indices" related to learning ability increased. Further, when exposed to the airflow from the front, the concentration index at the airflow intensity of 0.3m/s is greatly increased, and when exposed to the airflow from the right, the concentration index at the airflow intensities of 0.3m/s and 0.5m/s is greatly increased. This is shown in table 1.4 below.
< table 1.4> relationship between direction and intensity of airflow and brain wave index
Plus, -the following: the increase or decrease is more than 20% when exposed to the airflow compared with the case when not exposed to the airflow
As described above, by applying the brain activity improving machine to the learning space, the comfortable airflow generated by the airflow generating device exerts a positive influence on the brain activity of the student to increase the concentration, and it can be seen from the electrocardiographic measurement that the positive influence is exerted on the body and the physiology.
Fig. 3B to 3F are views showing various shapes of the casing of the brain activity improving machine to be compatible with various indoor environments.
FIG. 3B is a box-shaped box body, FIG. 3C is a honeycomb-shaped box body, and FIG. 3D is "
"case in shape", fig. 3E case in shape of cone, and fig. 3F case in shape of horn. Fig. 3B to 3F each include, although not shown, an airflow generating device 100, an air blowing device 200, a control unit 400, and a dust filter 23.
Hereinafter, still another embodiment according to the present invention will be described in detail with reference to the accompanying drawings.
Fig. 5 is a perspective view showing a hydrogen generating apparatus according to still another embodiment of the present invention, fig. 6 is a conceptual diagram of a skin aging prevention machine according to still another embodiment of the present invention, fig. 7A is a perspective view of a skin aging prevention machine according to still another embodiment of the present invention, fig. 7B is a perspective view of a skin aging prevention machine according to still another embodiment of the present invention, fig. 8A is experimental data showing the relative concentration of mmp (matrixmetalloprotenase) when the skin aging prevention machine according to still another embodiment of the present invention is used and not used, and fig. 8B is experimental data showing the relative concentration of mRNA when the skin aging prevention machine according to still another embodiment of the present invention is used and not used.
Referring to fig. 5 to 7, a skin aging prevention machine according to one embodiment of the present invention includes a case 10 a; an air suction port 11a formed at a lower portion of the case 10a to constitute a suction passage of air; a hydrogen generation device 100a for generating hydrogen; a blower 200a provided on one side of the hydrogen generator 100 a; a control unit 300a for controlling the hydrogen generation device 100a and the blower device 200 a; and an ejection port 15a for ejecting the hydrogen atoms generated by the hydrogen generator 100a to the skin.
The control unit 300a includes: a display unit 310a for informing an action state of the skin aging prevention apparatus; an operation unit 320a for adjusting the operation and blowing speed of the hydrogen generator 100a and the blower 200 a; and a power supply unit 330a for supplying power to the hydrogen generator 100a and the blower 200 a.
As shown in fig. 5 and 6, the hydrogen generator 100a includes a ceramic plate unit 111a disposed on the upper surface of the body 110 a; the needle electrodes 112a are disposed at a predetermined distance from the ceramic plate unit 111 a.
The upper surface of the body 110a is provided with a concave space for disposing the ceramic plate unit 111a, in which the ceramic plate unit 111a is inserted. The ceramic plate unit 111a is a unit for generating hydrogen ions, and a discharge electrode 114a is provided at an upper portion in the ceramic plate unit 111a, and a sensing electrode 115a is provided at an inner center. The portions other than the discharge electrode 114a and the inductive electrode 115a are formed of ceramic to form a protective layer.
A positive high voltage is applied between the discharge electrode 114a and the inductive electrode 115 a. Thus, when a positive high voltage is applied between the discharge electrode 114a and the inductive electrode 115a, moisture (H) in the air is generated in the ceramic plate unit 111a by the plasma discharge2O) is electrolyzed to generate hydrogen ions (H)+)。
On the other hand, a negative high voltage is applied between the needle electrode 112a and the ground electrode 117 a. When a negative high voltage is applied to the needle electrode 112a in this way, positive ions are collected around the needle electrode 112a by plasma discharge, and a large number of electrons are emitted from the needle electrode 112a into the air. Since a large number of electrons emitted into the air are very unstable, oxygen molecules (O) are generated2) Capture to form superoxide ion (O)2 -). Therefore, when a negative high voltage is applied to the needle electrode 112a, electrons (e) and superoxide ions (O) are generated2 -)。
Further, if electrons are emitted from the needle electrodes 112a, the electrons combine with hydrogen ions generated by the ceramic plate unit 111a and flowing around the needle electrodes 112a to generate hydrogen atoms (or active hydrogen). At this time, the blower 200a provided on one side of the hydrogen generator 100a forcibly sends the hydrogen ions generated from the ceramic plate unit 111a to the needle electrodes 112a so as to be well combined with the electrons generated from the needle electrodes 112 a.
The needle electrodes 112a are disposed at a predetermined distance from the ceramic plate unit 111 a. The number of hydrogen ions generated from the ceramic plate unit 111a converted into hydrogen atoms varies with the separation distance between the needle electrodes 112a and the ceramic plate unit 111a, and thus it is preferable to adjust the separation distance between the two according to the size of the ceramic plate unit 111a, the height of the needle electrodes 112a, and the like.
Thus, the device is provided withSince the hydrogen ions generated from the ceramic plate unit 111a are combined with the electrons emitted from the needle electrode 112a to generate hydrogen atoms, the substances finally discharged from the hydrogen generator 100a are hydrogen atoms (H) and superoxide ions (O)2 -)。
Further, the ejection port 15a is provided so that the hydrogen atoms and superoxide ions can be ejected onto the skin. Although this ejection port 15a is shown as a circular surface having a plurality of holes formed therein in fig. 7A, any shape that facilitates the discharge of hydrogen atoms to the skin may be used. Further, the ejection port 15a may be replaced with another shape as necessary.
Hereinafter, the operation of the skin-aging prevention machine will be described by way of yet another embodiment according to the present invention.
When the user operates the skin aging prevention apparatus by operating the operation unit 320a provided in the control unit 300a, the air sucked through the air suction port 11a is sent to the hydrogen generator 100 a. Hydrogen ions are generated using air by applying a positive high voltage between the discharge electrode 114a and the induction electrode 115a of the ceramic plate unit 111a, and electrons and superoxide ions are generated by applying a negative high voltage to the needle electrode 112 a. Then, the hydrogen ions are caused to flow through the needle electrode 112a or the periphery of the needle electrode 112a by the air blown by the air blowing device 200 a. When the hydrogen ions approach the needle electrode 112a, the hydrogen ions are combined with electrons around the needle electrode 112a to form hydrogen atoms, and are discharged from the discharge port 15a to the outside together with the superoxide ions generated by the needle electrode 112 a.
The hydrogen atoms discharged to the outside are in contact with the skin of the human body. The hydrogen atom reduces the concentration of mRNA, which is a genetic factor for producing the protease MMP in the skin, and as the concentration of mRNA decreases, the concentration of MMP in the skin also decreases. Thus, the MMP concentration that inhibits the production of proteins in the skin, i.e., collagen, is reduced, the phenomenon of collagen deficiency is prevented, and the generation of wrinkles, which is one of the skin aging phenomena, is suppressed. Fig. 8A and 8B are experimental data showing the relative concentrations of MMP and mRNA when the skin was exposed to ultraviolet light, and when hydrogen atoms were released or not released to the skin. The horizontal axis C (control group) represents the case where the skin aging prevention device is not used, and H (experimental group) represents the case where the skin aging prevention device is used. The experimental results show that the effect of reducing the concentrations of MMP and mRNA is significant when hydrogen atoms are discharged into the skin.
Fig. 7B is a perspective view of a skin aging prevention machine according to still another embodiment of the present invention, and only portions different from one embodiment of the present invention will be described, and description of the same portions will be omitted.
The skin-aging preventing machine according to the embodiment of fig. 7B includes a case 20 a; an air suction port 21a formed in the rear of the case 20 a; a hydrogen generation device 100a for generating hydrogen; a control unit 300a formed at one side of the case; an ejection port 25a for ejecting the hydrogen atoms generated by the hydrogen generator 100a onto the skin; a hair band 28a attached to the case 20 a.
The skin-aging prevention machine according to the present embodiment has a hair band 28a to be able to be brought onto a head 800a of a person. The hair band 28a has a length that can be attached to the head 800a, and is preferably made of an elastic material for easy attachment to the head 800 a. The discharge port 25a faces the face, so that hydrogen atoms can be intensively discharged to the face.
The invention has been shown and described with respect to certain preferred embodiments. However, the present invention is not limited to the above-described embodiments, and a person having ordinary knowledge in the technical field to which the present invention belongs can make various modifications and implement the present invention without departing from the gist of the technical idea of the present invention described in the appended claims.
Claims (19)
1. A brain activity improving machine is characterized by comprising an airflow generating device which changes brain waves and an electrocardiogram.
2. The brain activity improving machine according to claim 1, wherein said air flow generating means includes:
a ceramic plate unit for generating hydrogen ions;
and an electron generation unit disposed spaced apart from the ceramic plate unit for generating electrons and negative ions.
3. The brain activity improving machine according to claim 2, wherein:
the ceramic plate unit includes a discharge electrode and an induction electrode, and a positive high voltage is applied between the discharge electrode and the induction electrode to generate hydrogen ions.
4. The brain activity improving machine according to claim 2,
the electron generating unit comprises a needle electrode, and electrons are discharged into the air when negative high voltage is applied to the needle electrode;
the electrons combine with oxygen molecules in the air to generate superoxide ions (O)2 -) With the hydrogen ion (H)+) Combine to form a hydrogen atom (H).
5. A brain activity improvement machine, characterized by comprising:
a box body;
an air suction inlet formed at one side of the case;
the gas flow generating device comprises a ceramic plate unit for generating hydrogen ions and an electron generating unit which is arranged at a distance from the ceramic plate unit and is used for generating electrons and superoxide ions;
and an ejection port for ejecting the superoxide ions and hydrogen atoms generated by the airflow generating device to the head.
6. The brain activity improving machine according to claim 5,
the brain activity improving machine further comprises an air supply device.
7. The brain activity improving machine according to claim 5,
the brain activity improving machine further includes a recognition sensor that recognizes the head.
8. The brain activity improving machine according to claim 7,
the brain activity improving machine further comprises a control unit for controlling the action.
9. The brain activity improving machine according to claim 8,
the brain activity improving machine further includes a dust filter at the air intake port.
10. The brain activity improving machine according to claim 8,
the recognition sensor is used for recognizing the front of the head.
11. The brain activity improving machine according to claim 8,
the recognition sensor is used for recognizing the right side surface of the head.
12. Brain activity improvement machine according to claim 10 or 11,
the brain movement improving machine further includes a rotating motor that rotates the direction of the ejection port in accordance with the portion identified by the identification sensor.
13. A skin aging prevention machine characterized by comprising:
a box body;
an air suction inlet formed at one side of the case;
a hydrogen generating means for generating hydrogen atoms;
an ejection port that ejects hydrogen atoms generated by the hydrogen generation device to the skin; wherein,
the hydrogen generating apparatus includes a ceramic plate unit for generating hydrogen ions and an electron generating unit spaced apart from the ceramic plate unit for generating electrons.
14. The skin aging prevention machine according to claim 13,
the ceramic plate unit includes a discharge electrode and an induction electrode, and a positive high voltage is applied between the discharge electrode and the induction electrode to generate hydrogen ions.
15. The skin aging prevention machine according to claim 13,
the electron generating unit is a needle electrode, and when a negative high voltage is applied to the needle electrode, electrons are emitted into the air, and the electrons are combined with the hydrogen ions to generate hydrogen atoms (H).
16. The skin aging prevention machine of claim 15,
the hydrogen atoms reduce the concentration of matrix metalloproteinases in the skin.
17. The skin aging prevention machine of claim 15,
the skin aging prevention apparatus further includes an air blowing device for sending the hydrogen ions generated by the ceramic plate unit to the electrons emitted by the needle electrodes.
18. The skin aging prevention machine of claim 17,
the skin aging prevention apparatus further includes a control unit for controlling the hydrogen generation device and the air supply device.
19. The skin aging prevention machine according to claim 13,
the skin aging prevention machine further includes a hair band for being brought to the head.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020080126560A KR20100067950A (en) | 2008-12-12 | 2008-12-12 | Device for preventing skin aging |
| KR10-2008-0126560 | 2008-12-12 | ||
| KR1020080128348A KR20100069815A (en) | 2008-12-17 | 2008-12-17 | Brain action improvement apparatus |
| KR10-2008-0128348 | 2008-12-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101745182A true CN101745182A (en) | 2010-06-23 |
Family
ID=42347668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910221719A Pending CN101745182A (en) | 2008-12-12 | 2009-11-11 | Device for improving action of head and device for preventing skin aging |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP2010137047A (en) |
| CN (1) | CN101745182A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104138630A (en) * | 2014-07-30 | 2014-11-12 | 北京银河之舟环保科技有限公司 | Respiratory tract drug delivery device and method |
| TWI581818B (en) * | 2015-10-30 | 2017-05-11 | 國立中央大學 | System and method for electric brain stimulator |
| CN111295216A (en) * | 2017-11-09 | 2020-06-16 | 水银行股份有限公司 | Health management system and program for the same |
| CN111386639A (en) * | 2017-11-28 | 2020-07-07 | 夏普株式会社 | Ion generating device, appliance, method for providing air conditioner-conditioned space, pressure reducing method, concentration improving method, and comfort improving method |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5265737B2 (en) * | 2010-09-06 | 2013-08-14 | シャープ株式会社 | Method and apparatus for preventing or treating atopic dermatitis |
| JP6039315B2 (en) * | 2012-08-31 | 2016-12-07 | シャープ株式会社 | Beauty equipment |
| US20160334121A1 (en) * | 2014-01-14 | 2016-11-17 | Panasonic Intellectual Property Management Co., Ltd. | Environment control system, control device, program |
| JP2016171840A (en) * | 2015-03-16 | 2016-09-29 | パナソニックＩｐマネジメント株式会社 | Environment control system, control device, and program |
| JP2018184369A (en) * | 2017-04-26 | 2018-11-22 | 株式会社明治 | Intellectual work ability improvement composition and cognition ability improvement composition |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1727010A (en) * | 2004-07-27 | 2006-02-01 | 三星电子株式会社 | Sterilization method and decontaminating apparatus and use their air cleaner method and apparatus |
| CN1779694A (en) * | 2004-11-26 | 2006-05-31 | 上海银晨智能识别科技有限公司 | Image identifier based on infrared image |
| CN2906410Y (en) * | 2006-02-28 | 2007-05-30 | 吴金春 | Air cleaner |
| CN101226587A (en) * | 2007-01-15 | 2008-07-23 | 中国科学院自动化研究所 | Image collecting device as well as human face identification system and method using the same |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003187945A (en) * | 2001-12-13 | 2003-07-04 | Nippon Gureen Kenkyusho:Kk | Air ion generator and supply method of air ion |
| KR100725807B1 (en) * | 2004-07-27 | 2007-06-08 | 삼성전자주식회사 | Ion generating device and Air conditioner comprising it |
| JP2007107809A (en) * | 2005-10-13 | 2007-04-26 | Matsushita Electric Ind Co Ltd | Air conditioner |
-
2009
- 2009-11-11 CN CN200910221719A patent/CN101745182A/en active Pending
- 2009-11-11 JP JP2009258140A patent/JP2010137047A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1727010A (en) * | 2004-07-27 | 2006-02-01 | 三星电子株式会社 | Sterilization method and decontaminating apparatus and use their air cleaner method and apparatus |
| CN1779694A (en) * | 2004-11-26 | 2006-05-31 | 上海银晨智能识别科技有限公司 | Image identifier based on infrared image |
| CN2906410Y (en) * | 2006-02-28 | 2007-05-30 | 吴金春 | Air cleaner |
| CN101226587A (en) * | 2007-01-15 | 2008-07-23 | 中国科学院自动化研究所 | Image collecting device as well as human face identification system and method using the same |
Non-Patent Citations (1)
| Title |
|---|
| 董力赓；陶霖密；徐光祐: "头部姿态和动作的识别与理解", 《第三届和谐人机环境联合学术会议》 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104138630A (en) * | 2014-07-30 | 2014-11-12 | 北京银河之舟环保科技有限公司 | Respiratory tract drug delivery device and method |
| CN104138630B (en) * | 2014-07-30 | 2017-05-10 | 北京银河之舟科技有限公司 | Respiratory tract drug delivery device and method |
| TWI581818B (en) * | 2015-10-30 | 2017-05-11 | 國立中央大學 | System and method for electric brain stimulator |
| CN111295216A (en) * | 2017-11-09 | 2020-06-16 | 水银行股份有限公司 | Health management system and program for the same |
| CN111295216B (en) * | 2017-11-09 | 2022-06-14 | 水银行股份有限公司 | Health management system and program for the same |
| CN111386639A (en) * | 2017-11-28 | 2020-07-07 | 夏普株式会社 | Ion generating device, appliance, method for providing air conditioner-conditioned space, pressure reducing method, concentration improving method, and comfort improving method |
| CN111386639B (en) * | 2017-11-28 | 2022-11-01 | 夏普株式会社 | Ion generating device, appliance, method for providing air conditioner conditioned space |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010137047A (en) | 2010-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101745182A (en) | Device for improving action of head and device for preventing skin aging | |
| US9826916B2 (en) | Device and method for examining a phase distribution used to determine a pathological interaction between different areas of the brain | |
| Blackburn | Cortical and autonomic arousal in primary and secondary psychopaths | |
| US8244341B2 (en) | Method and device for determining depressive disorders by measuring bioelectromagnetic signals of the brain | |
| CN105771097A (en) | Intelligent pillow | |
| KR102037970B1 (en) | Apparatus of Measuring Electroencephalography, And System and Method for Diagnosing and preventing Dementia | |
| CN105797270A (en) | Smart system and method for promoting sleep quality | |
| KR20130005802A (en) | Eye-and-ear mask device for inducing personalized sleep and method for driving the same | |
| KR101480536B1 (en) | Electroencephalogram detecting system including a portable electroencephalogram detecting apparatus of hair band type, and a sleep management method using the same | |
| Rahman et al. | Mental stress recognition using K-nearest neighbor (KNN) classifier on EEG signals | |
| Chen et al. | Amplitude of fNIRS resting-state global signal is related to EEG vigilance measures: A simultaneous fNIRS and EEG study | |
| AU2022221742A1 (en) | Apparatus, systems and methods for monitoring symptoms of neurological conditions | |
| JP7075648B2 (en) | A computer program product that executes a brain function disease identification method and a program including the method. | |
| CN110812707B (en) | Brain imaging and light nerve regulation and control integrated device | |
| Youn et al. | Effects of green walls on prefrontal cerebral hemodynamics in hospital workers | |
| US20030229291A1 (en) | System for reduction of undesirable brain wave patterns using selective photic stimulation | |
| KR20080039805A (en) | Apparatus and method for neuro feedback | |
| CN117503160A (en) | Clinical diagnosis and treatment device | |
| KR101693716B1 (en) | brain function analysis method and apparatus to detect attention reduction | |
| Drozdenko et al. | The Influence of a Low-Frequency Musical Fragment on the Neural Oscillations | |
| KR102569058B1 (en) | Patch type polysomnography apparatus and method | |
| Brand et al. | Olfaction and hemispheric asymmetry: unilateral stimulation and bilateral electrodermal recordings | |
| KR20100069815A (en) | Brain action improvement apparatus | |
| Nugroho et al. | An application real-time acquiring EEG signal from single lead electrode to recognize brain activity using Neurosky sensor | |
| KR20130001526A (en) | Realtime monitoring/treatment device for stimulation of acupuncture channels |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20100623 |